Isenschmid D S, Levine B S, Caplan Y H
Southgate Medical Services, Inc., Cleveland, Ohio 44137.
J Anal Toxicol. 1992 Sep-Oct;16(5):319-24. doi: 10.1093/jat/16.5.319.
A study of the metabolism of in vivo cocaine (COC) and the stability of in vitro COC suggests that the presence of benzoylecgonine (BE) in unpreserved blood arises from in vivo COC metabolism and that ecgonine methyl ester (EME) in unpreserved blood arises from in vitro COC hydrolysis. Postmortem cases positive for COC were studied to determine if molar concentrations of EME in unpreserved blood could be used to estimate the blood COC concentration at the time of death when added to the molar COC concentrations. COC was analyzed in 10 postmortem blood specimens between 1 and 8 days following death and again 10 to 70 days after further storage. The COC lost was accounted for by its hydrolysis to EME. Good correlation (r = 0.9677, p < 0.001) was observed when the blood COC concentrations in postmortem cases were compared to blood COC concentrations predicted by the addition of blood COC and EME concentrations; hence, analysis for EME and estimation of perimortem COC concentrations can assist in defining deaths associated with COC use.
一项关于体内可卡因(COC)代谢及体外COC稳定性的研究表明,未保存血液中苯甲酰芽子碱(BE)的存在源于体内COC代谢,而未保存血液中芽子碱甲酯(EME)则源于体外COC水解。对COC呈阳性的尸检案例进行研究,以确定未保存血液中EME的摩尔浓度与死亡时血液COC浓度相加后,是否可用于估算死亡时的血液COC浓度。在死亡后1至8天对10份尸检血液标本中的COC进行分析,进一步储存10至70天后再次分析。COC的损失是由于其水解为EME。当将尸检案例中的血液COC浓度与通过添加血液COC和EME浓度预测的血液COC浓度进行比较时,观察到良好的相关性(r = 0.9677,p < 0.001);因此,对EME的分析及死亡时COC浓度的估算有助于确定与使用COC相关的死亡情况。